NewslettersDermal Cell NewsIovance Biotherapeutics Announces US FDA Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced MelanomaBy Laurisa Dohm - May 29, 2023082Iovance Biotherapeutics, Inc. announced that the US FDA accepted its Biologics License Application for lifileucel for patients with advanced melanoma.[Iovance Biotherapeutics, Inc.]Press Release